Document ID: chunk:federal_register_of_legislation:F2024C01228:front:0:p6
Version: federal_register_of_legislation:F2024C01228
Segment Type: other
Provision Reference: 
Character Range: 12581–15653

of the vaccine may be provided to a child mentioned in paragraph (b) 5 months after the second dose was provided to the child under paragraph (c).
 (5) For items 205, 208, 209 and 210 of Schedule 1, a designated vaccine mentioned in those items may be provided to:
 (a) a person who is at least 65 years; or
 (b) an Aboriginal and/or Torres Strait Islander person who is:
 (i) aged at least 6 months but less than 5 years; or
 (ii) 15 years or older; or
 (c) a person who is at least 6 months
 (i) who:
 (A) has cardiac disease including cyanotic congenital heart disease, coronary artery disease and congestive heart failure; or
 (B) has a chronic respiratory condition including suppurative lung disease, bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease, chronic emphysema and severe asthma; or
 (C) has another chronic illness requiring regular medical follow‑up or hospitalisation in the preceding year, including diabetes mellitus, chronic metabolic diseases, chronic renal failure, haemoglobinopathies and impaired immunity (including drug‑induced immune impairment); or
 (D) has a chronic neurological condition, including multiple sclerosis, spinal cord injuries, seizure disorders or other neuromuscular disorders; or
 (E) has impaired immunity, including HIV infection; or
 (F) is aged 6 months to 10 years and is receiving long‑term aspirin therapy; or
 (G) is pregnant.

     (6)  For item 206 of Schedule 1, a designated vaccine mentioned in that item may be provided to a person who is at least 65 years of age.

     (7)  For item 207 of Schedule 1, a designated vaccine mentioned in those items may be provided to:
         (a)  a person who is at least 65 years; or
          (b) an Aboriginal and/or Torres Strait Islander person who is at least 15 years; or
         (c)  a person who is at least 5 years
             (i) who:
                  (A) has cardiac disease including cyanotic congenital heart disease, coronary artery disease and congestive heart failure; or
                  (B) has a chronic respiratory condition including suppurative lung disease, bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease, chronic emphysema and severe asthma; or
                  (C) has another chronic illness requiring regular medical follow‑up or hospitalisation in the preceding year, including diabetes mellitus, chronic metabolic diseases, chronic renal failure, haemoglobinopathies and impaired immunity (including drug‑induced immune impairment); or
                  (D) has a chronic neurological condition, including multiple sclerosis, spinal cord injuries, seizure disorders or other neuromuscular disorders; or
                  (E) has impaired immunity, including HIV infection; or
                  (F) is aged 5 to 10 years and is receiving long‑term aspirin therapy; or
                  (G) is pregnant.

     (8)  For item 207A, 207B and 207F of Schedule 1, a designated vaccine mentioned in that item may be provided to any of the following:
         (a)  a person who is at least 65 years old